Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos
ilustraciones, diagramas
- Autores:
-
Patiño Soler, Mauricio
- Tipo de recurso:
- Fecha de publicación:
- 2024
- Institución:
- Universidad Nacional de Colombia
- Repositorio:
- Universidad Nacional de Colombia
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unal.edu.co:unal/85722
- Palabra clave:
- 610 - Medicina y salud::615 - Farmacología y terapéutica
610 - Medicina y salud::616 - Enfermedades
Síndrome Post Agudo de COVID-19
Terapias Complementarias
Manejo del Dolor/métodos
Pain Management/methods
Post-Acute COVID-19 Syndrome
Complementary Therapies
Post-vacuna COVID-19
Medicina neuralterapéutica
Dolor musculoesquelético
Medicina alternativa
Post-COVID-19 vaccine
Neural therapeutic medicine
Musculoskeletal pain
Alternative medicine
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional
| id |
UNACIONAL2_2da7a58821460da38e1d7175743ddf11 |
|---|---|
| oai_identifier_str |
oai:repositorio.unal.edu.co:unal/85722 |
| network_acronym_str |
UNACIONAL2 |
| network_name_str |
Universidad Nacional de Colombia |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| dc.title.translated.eng.fl_str_mv |
The onset of musculeskeletal pain managment after the COVID-19 vaccine with neuraltherapeutic medicine treatment: Series |
| title |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| spellingShingle |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos 610 - Medicina y salud::615 - Farmacología y terapéutica 610 - Medicina y salud::616 - Enfermedades Síndrome Post Agudo de COVID-19 Terapias Complementarias Manejo del Dolor/métodos Pain Management/methods Post-Acute COVID-19 Syndrome Complementary Therapies Post-vacuna COVID-19 Medicina neuralterapéutica Dolor musculoesquelético Medicina alternativa Post-COVID-19 vaccine Neural therapeutic medicine Musculoskeletal pain Alternative medicine |
| title_short |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| title_full |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| title_fullStr |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| title_full_unstemmed |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| title_sort |
Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos |
| dc.creator.fl_str_mv |
Patiño Soler, Mauricio |
| dc.contributor.advisor.spa.fl_str_mv |
Amaris Peña, Oscar Pinilla Bonilla, Laura Bibiana |
| dc.contributor.author.spa.fl_str_mv |
Patiño Soler, Mauricio |
| dc.subject.ddc.spa.fl_str_mv |
610 - Medicina y salud::615 - Farmacología y terapéutica 610 - Medicina y salud::616 - Enfermedades |
| topic |
610 - Medicina y salud::615 - Farmacología y terapéutica 610 - Medicina y salud::616 - Enfermedades Síndrome Post Agudo de COVID-19 Terapias Complementarias Manejo del Dolor/métodos Pain Management/methods Post-Acute COVID-19 Syndrome Complementary Therapies Post-vacuna COVID-19 Medicina neuralterapéutica Dolor musculoesquelético Medicina alternativa Post-COVID-19 vaccine Neural therapeutic medicine Musculoskeletal pain Alternative medicine |
| dc.subject.decs.spa.fl_str_mv |
Síndrome Post Agudo de COVID-19 Terapias Complementarias Manejo del Dolor/métodos |
| dc.subject.decs.eng.fl_str_mv |
Pain Management/methods Post-Acute COVID-19 Syndrome Complementary Therapies |
| dc.subject.proposal.spa.fl_str_mv |
Post-vacuna COVID-19 Medicina neuralterapéutica Dolor musculoesquelético Medicina alternativa |
| dc.subject.proposal.eng.fl_str_mv |
Post-COVID-19 vaccine Neural therapeutic medicine Musculoskeletal pain Alternative medicine |
| description |
ilustraciones, diagramas |
| publishDate |
2024 |
| dc.date.accessioned.none.fl_str_mv |
2024-02-26T19:37:52Z |
| dc.date.available.none.fl_str_mv |
2024-02-26T19:37:52Z |
| dc.date.issued.none.fl_str_mv |
2024 |
| dc.type.spa.fl_str_mv |
Trabajo de grado - Maestría |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/acceptedVersion |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/TM |
| status_str |
acceptedVersion |
| dc.identifier.uri.none.fl_str_mv |
https://repositorio.unal.edu.co/handle/unal/85722 |
| dc.identifier.instname.spa.fl_str_mv |
Universidad Nacional de Colombia |
| dc.identifier.reponame.spa.fl_str_mv |
Repositorio Institucional Universidad Nacional de Colombia |
| dc.identifier.repourl.spa.fl_str_mv |
https://repositorio.unal.edu.co/ |
| url |
https://repositorio.unal.edu.co/handle/unal/85722 https://repositorio.unal.edu.co/ |
| identifier_str_mv |
Universidad Nacional de Colombia Repositorio Institucional Universidad Nacional de Colombia |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.indexed.spa.fl_str_mv |
Bireme |
| dc.relation.references.spa.fl_str_mv |
Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed [Internet]. 2020 [cited 2022 Jun 8];91(1):157–60. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569573/ Miller E. Rapid evaluation of the safety of COVID-19 vaccines: how well have we done? Commentary on “Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study.” Clinical Microbiology and Infection [Internet]. 2022 Jan 5 [cited 2022 Jan 26];0(0). Available from: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00726-6/fulltext#secsectitle0015 Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies. Journal of Autoimmunity [Internet]. 2022 Jan 1 [cited 2022 Jan 20];126:102779. Available from: https://www.sciencedirect.com/science/article/pii/S0896841121001876 Stanghellini MTL, Cosimo SD, Costantini M, Monti S, Mantegazza R, Mantovani A, et al. mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients [Internet]. Oncology; 2022 Jan [cited 2022 Jan 26]. Available from: http://medrxiv.org/lookup/doi/10.1101/2022.01.18.22269351 Renoud L, Khouri C, Revol B, Lepelley M, Perez J, Roustit M, et al. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database. JAMA Internal Medicine [Internet]. 2021 Sep 1 [cited 2022 Jan 26];181(9):1243–5. Available from: https://doi.org/10.1001/jamainternmed.2021.2219 Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med [Internet]. 2021 Dec [cited 2022 Jan 26];27(12):2144–53. Available from: https://www.nature.com/articles/s41591-021-01556-7 Sodhi M, Samii A, Etminan M. A comparative safety study of reported neurological adverse events with three COVID-19 vaccines. J Neurol [Internet]. 2022 Jan 9 [cited 2022 Jan 26]; Available from: https://doi.org/10.1007/s00415-021-10919-6 Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ [Internet]. 2021 May 5 [cited 2022 Jan 26];373:n1114. Available from: https://www.bmj.com/content/373/bmj.n1114 Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyártó BZ. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience [Internet]. 2021 Dec 17 [cited 2022 Jan 27];24(12):103479. Available from: https://www.sciencedirect.com/science/article/pii/S2589004221014504 Gundry SR. Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation [Internet]. 2021 Nov 16 [cited 2022 Jan 27];144(Suppl_1):A10712–A10712. Available from: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 Liu J, Wang J, Xu J, Xia H, Wang Y, Zhang C, et al. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines | Cell Discovery. Cell Discov [Internet]. 2021 Oct 26 [cited 2022 Feb 8];(99). Available from: https://www.nature.com/articles/s41421-021-00329-3 Alsaiari AA, Allahyani M, Aljuaid A, Shafie A, Al-hazmi A, Dahlawi HA, et al. Assessing the adverse effects of COVID-19 vaccine in different scenarios in Saudi Arabia. Saudi Med J [Internet]. 2023 Feb [cited 2023 Mar 28];44(2):194–201. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987704/ Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, et al. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Research & Therapy [Internet]. 2022 Jan 11 [cited 2023 Mar 28];24(1):21. Available from: https://doi.org/10.1186/s13075-021-02674-w Acanfora D, Nolano M, Acanfora C, Colella C, Provitera V, Caporaso G, et al. Impaired Vagal Activity in Long-COVID-19 Patients. Viruses [Internet]. 2022 May [cited 2023 May 26];14(5):1035. Available from: https://www.mdpi.com/1999-4915/14/5/1035 Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol [Internet]. 2022 [cited 2023 May 26];41(5):1603–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979721/ Finsterer J. Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurol Scand [Internet]. 2022 Jan [cited 2023 May 26];145(1):5–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653194/ Oonk NGM, Ettema AR, van Berghem H, de Klerk JJ, van der Vegt JPM, van der Meulen M. SARS-CoV-2 vaccine-related neurological complications. Neurol Sci [Internet]. 2022 Jan 20 [cited 2022 Jan 26]; Available from: https://doi.org/10.1007/s10072-022-05898-z Pavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci [Internet]. 2017 Feb [cited 2023 May 26];20(2):156–66. Available from: https://www.nature.com/articles/nn.4477 Johnson RL, Wilson CG. A review of vagus nerve stimulation as a therapeutic intervention. J Inflamm Res [Internet]. 2018 May 16 [cited 2023 May 26];11:203–13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961632/ Vischnevsky AV, Vischnevsky AA. El bloqueo novocainico y los antisépticos oleobalsámicos como forma de terapéutica patogénica. Argentina: Editorial Cartago; 1958. 200 p. Bustamante C, Pinilla L, Amaris O. An Approach to Acute SARS-CoV-2 Management with Complementary Neuraltherapeutic Medicine: A Case Report. Clin Med Insights Case Rep [Internet]. 2023 Apr 5 [cited 2023 May 26];16:11795476231159584. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076607/ Kawano-Hokama M, Shiratori-Tusita L, Pinilla-Bonilla L, Cruz-Rodríguez Y. The potential role of trigeminal nerve irritation in the pathophysiology of Bell’s palsy. A case report from a Neural Therapy perspective. Case reports [Internet]. 2022;8(2). Available from: https://revistas.unal.edu.co/index.php/care/article/view/93840 Asociación Colombiana de Terapia Neural / Medicina Neuralterapéutica (ACOLTEN/MNT), Asociación Colombiana de Terapia Neural Julio César Payán de la Roche. Asociación Colombiana de Terapia Neural (ACOLTEN MNT) en contexto de pandemia. Colombia; 2020 Jun p. 83. Engel R, Barop H, Giebel J, Ludin SM, Fischer L. The Influence of Modern Neurophysiology on the Previous Definitions of “Segment” and “Interference Field” in Neural Therapy. Complement Med Res [Internet]. 2022 [cited 2022 Jun 27];29(3):257–67. Available from: https://www.karger.com/Article/FullText/522391 Polymyalgia Rheumatica After ChAdOx1 nCov-19 Vaccine: A Case Report - PMC [Internet]. [cited 2023 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236670/ Pinilla L. Validez y fuerza científica de los fundamentos de la Terapia Neural: un estudio de la obra de Speransky. In: Medicina neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá: Universidad Nacional de Colombia; 2013. Toscano de la Torre F, Pinilla Bonilla LB. Los principios de la terapia neural desde los fundamentos del nervismo hasta la neurociencia actual. Rev Univ Ind Santander Salud [Internet]. 2012 [cited 2022 Jan 27];44(2):57–65. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072012000200008 Salazar J. La terapia neural: de terapia {ortodoxa" a Medicina Neuralterapéutica. In: Medicina Neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá: Universidad Nacional de Colombia; 2013. p. 51–72. Vinyes D, Muñoz-Sellart M, Caballero TG. Local anesthetics as a therapeutic tool for post COVID-19 patients: A case report. Medicine [Internet]. 2022 Jul 15 [cited 2023 May 26];101(28):e29358. Available from: https://journals.lww.com/md-journal/Fulltext/2022/07150/Local_anesthetics_as_a_therapeutic_tool_for_post.33.aspx Altinbilek T, Terzi R, Kaya E, Murat S. Effects of Local Anesthetics on Viruses from a Neural Therapy Perspective. J Tradit Complem Med. 2021;4(3):394–9. Fu Q, Xie H, Zhou L, Li X, Liu Y, Liu M, et al. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Trials [Internet]. 2021 Feb 25 [cited 2023 Sep 27];22:162. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905419/ |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.license.spa.fl_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional |
| dc.rights.uri.spa.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
xii, 21 páginas |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Universidad Nacional de Colombia |
| dc.publisher.program.spa.fl_str_mv |
Bogotá - Medicina - Maestría en Medicina Alternativa |
| dc.publisher.faculty.spa.fl_str_mv |
Facultad de Medicina |
| dc.publisher.place.spa.fl_str_mv |
Bogotá, Colombia |
| dc.publisher.branch.spa.fl_str_mv |
Universidad Nacional de Colombia - Sede Bogotá |
| institution |
Universidad Nacional de Colombia |
| bitstream.url.fl_str_mv |
https://repositorio.unal.edu.co/bitstream/unal/85722/1/license.txt https://repositorio.unal.edu.co/bitstream/unal/85722/2/1125785403.2024.pdf https://repositorio.unal.edu.co/bitstream/unal/85722/3/1125785403.2024.pdf.jpg |
| bitstream.checksum.fl_str_mv |
eb34b1cf90b7e1103fc9dfd26be24b4a 2841460412b05ccbc904f7d43dfc00ef 676c04148f2ca1a83a467545415ce527 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Universidad Nacional de Colombia |
| repository.mail.fl_str_mv |
repositorio_nal@unal.edu.co |
| _version_ |
1814089847844896768 |
| spelling |
Atribución-NoComercial-SinDerivadas 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Amaris Peña, Oscarc23bfcd68500b415be50364e2a366203600Pinilla Bonilla, Laura Bibiana8cb1ca1e8a674bd91d7cd9fd826c793b600Patiño Soler, Mauricio8ab8576458a09d16a4001347378e30ef2024-02-26T19:37:52Z2024-02-26T19:37:52Z2024https://repositorio.unal.edu.co/handle/unal/85722Universidad Nacional de ColombiaRepositorio Institucional Universidad Nacional de Colombiahttps://repositorio.unal.edu.co/ilustraciones, diagramasLa vacunación contra SARS-Cov-2 ha disminuido la tasa de infección, severidad y mortalidad por COVID-19. Estudios sobre la respuesta inmune a las vacunas muestran un aumento en marcadores inflamatorios, algunos similares a COVID-19 severa. Algunos pacientes generan el síndrome post-vacuna de COVID-19, se ha propuesto que una respuesta inflamatoria persistente y la disfunción del nervio vago como explicación. La medicina neuralterapéutica puede ser usada para la regulación del sistema nervioso. Presentación de casos. Caso 1: Paciente femenina de 52 años con dolor crónico con aumento del dolor musculoesquelético posterior a la segunda dosis contra COVID-19. Caso 2: Paciente femenina de 73 años con dolor crónico en miembros superiores posterior a recibir vacunación contra COVID-19. Caso 3: Paciente femenina de 75 años con aparición de dolor en miembro superior derecho, rodillas y zona lumbar posterior a la vacunación contra COVID-19. Después del tratamiento con medicina neuralterapéutica hubo disminución del dolor en los tres casos. Conclusión. El dolor musculoesquelético posterior a vacunación contra COVID-19 es un efecto adverso que puede aparecer en partes distantes al sitio de vacunación. Los reportes de caso presentados describen la utilización de la medicina neuralterapéutica como una herramienta para el tratamiento de los síntomas post-vacunación. (Texto tomado de la fuente).Vaccination against SARS-Cov-2 has decreased the rate of infection, severity, and mortality rate from COVID-19. Studies on the immune response to vaccines show increased inflammatory markers, some similar to severe COVID-19. Some patients develop post-COVID-19 vaccine syndrome, a persistent inflammatory response, and vagus nerve dysfunction have been proposed as an explanation. Neuraltherapeutic medicine can be used for the regulation of the nervous system. Presentation of cases. Case 1: 52-year-old female patient with chronic pain with increased musculoskeletal pain after the second dose against COVID-19. Case 2: 73-year-old female patient with chronic pain in the upper limbs after receiving vaccination against COVID-19. Case 3: 75-year-old female patient with pain in the right upper limb, knees, and lower back after vaccination against COVID-19. After treatment with neuraltherapeutic medicine, there was a decrease in pain in all three cases. Conclusion. Musculoskeletal pain after vaccination against COVID-19 is an adverse effect that can appear in parts distant from the vaccination site. The case reports presented describe the use of neural therapeutic medicine as a tool for the treatment of postvaccination symptoms.MaestríaMagíster en Medicina AlternativaEstudio no experimental, descriptivo retrospectivo longitudinalxii, 21 páginasapplication/pdfspaUniversidad Nacional de ColombiaBogotá - Medicina - Maestría en Medicina AlternativaFacultad de MedicinaBogotá, ColombiaUniversidad Nacional de Colombia - Sede Bogotá610 - Medicina y salud::615 - Farmacología y terapéutica610 - Medicina y salud::616 - EnfermedadesSíndrome Post Agudo de COVID-19Terapias ComplementariasManejo del Dolor/métodosPain Management/methodsPost-Acute COVID-19 SyndromeComplementary TherapiesPost-vacuna COVID-19Medicina neuralterapéuticaDolor musculoesqueléticoMedicina alternativaPost-COVID-19 vaccineNeural therapeutic medicineMusculoskeletal painAlternative medicineManejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casosThe onset of musculeskeletal pain managment after the COVID-19 vaccine with neuraltherapeutic medicine treatment: SeriesTrabajo de grado - Maestríainfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/acceptedVersionTexthttp://purl.org/redcol/resource_type/TMBiremeCucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed [Internet]. 2020 [cited 2022 Jun 8];91(1):157–60. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569573/Miller E. Rapid evaluation of the safety of COVID-19 vaccines: how well have we done? Commentary on “Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study.” Clinical Microbiology and Infection [Internet]. 2022 Jan 5 [cited 2022 Jan 26];0(0). Available from: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00726-6/fulltext#secsectitle0015Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies. Journal of Autoimmunity [Internet]. 2022 Jan 1 [cited 2022 Jan 20];126:102779. Available from: https://www.sciencedirect.com/science/article/pii/S0896841121001876Stanghellini MTL, Cosimo SD, Costantini M, Monti S, Mantegazza R, Mantovani A, et al. mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients [Internet]. Oncology; 2022 Jan [cited 2022 Jan 26]. Available from: http://medrxiv.org/lookup/doi/10.1101/2022.01.18.22269351Renoud L, Khouri C, Revol B, Lepelley M, Perez J, Roustit M, et al. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database. JAMA Internal Medicine [Internet]. 2021 Sep 1 [cited 2022 Jan 26];181(9):1243–5. Available from: https://doi.org/10.1001/jamainternmed.2021.2219Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med [Internet]. 2021 Dec [cited 2022 Jan 26];27(12):2144–53. Available from: https://www.nature.com/articles/s41591-021-01556-7Sodhi M, Samii A, Etminan M. A comparative safety study of reported neurological adverse events with three COVID-19 vaccines. J Neurol [Internet]. 2022 Jan 9 [cited 2022 Jan 26]; Available from: https://doi.org/10.1007/s00415-021-10919-6Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ [Internet]. 2021 May 5 [cited 2022 Jan 26];373:n1114. Available from: https://www.bmj.com/content/373/bmj.n1114Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyártó BZ. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience [Internet]. 2021 Dec 17 [cited 2022 Jan 27];24(12):103479. Available from: https://www.sciencedirect.com/science/article/pii/S2589004221014504Gundry SR. Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation [Internet]. 2021 Nov 16 [cited 2022 Jan 27];144(Suppl_1):A10712–A10712. Available from: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712Liu J, Wang J, Xu J, Xia H, Wang Y, Zhang C, et al. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines | Cell Discovery. Cell Discov [Internet]. 2021 Oct 26 [cited 2022 Feb 8];(99). Available from: https://www.nature.com/articles/s41421-021-00329-3Alsaiari AA, Allahyani M, Aljuaid A, Shafie A, Al-hazmi A, Dahlawi HA, et al. Assessing the adverse effects of COVID-19 vaccine in different scenarios in Saudi Arabia. Saudi Med J [Internet]. 2023 Feb [cited 2023 Mar 28];44(2):194–201. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987704/Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, et al. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Research & Therapy [Internet]. 2022 Jan 11 [cited 2023 Mar 28];24(1):21. Available from: https://doi.org/10.1186/s13075-021-02674-wAcanfora D, Nolano M, Acanfora C, Colella C, Provitera V, Caporaso G, et al. Impaired Vagal Activity in Long-COVID-19 Patients. Viruses [Internet]. 2022 May [cited 2023 May 26];14(5):1035. Available from: https://www.mdpi.com/1999-4915/14/5/1035Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol [Internet]. 2022 [cited 2023 May 26];41(5):1603–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979721/Finsterer J. Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurol Scand [Internet]. 2022 Jan [cited 2023 May 26];145(1):5–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653194/Oonk NGM, Ettema AR, van Berghem H, de Klerk JJ, van der Vegt JPM, van der Meulen M. SARS-CoV-2 vaccine-related neurological complications. Neurol Sci [Internet]. 2022 Jan 20 [cited 2022 Jan 26]; Available from: https://doi.org/10.1007/s10072-022-05898-zPavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci [Internet]. 2017 Feb [cited 2023 May 26];20(2):156–66. Available from: https://www.nature.com/articles/nn.4477Johnson RL, Wilson CG. A review of vagus nerve stimulation as a therapeutic intervention. J Inflamm Res [Internet]. 2018 May 16 [cited 2023 May 26];11:203–13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961632/Vischnevsky AV, Vischnevsky AA. El bloqueo novocainico y los antisépticos oleobalsámicos como forma de terapéutica patogénica. Argentina: Editorial Cartago; 1958. 200 p.Bustamante C, Pinilla L, Amaris O. An Approach to Acute SARS-CoV-2 Management with Complementary Neuraltherapeutic Medicine: A Case Report. Clin Med Insights Case Rep [Internet]. 2023 Apr 5 [cited 2023 May 26];16:11795476231159584. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076607/Kawano-Hokama M, Shiratori-Tusita L, Pinilla-Bonilla L, Cruz-Rodríguez Y. The potential role of trigeminal nerve irritation in the pathophysiology of Bell’s palsy. A case report from a Neural Therapy perspective. Case reports [Internet]. 2022;8(2). Available from: https://revistas.unal.edu.co/index.php/care/article/view/93840Asociación Colombiana de Terapia Neural / Medicina Neuralterapéutica (ACOLTEN/MNT), Asociación Colombiana de Terapia Neural Julio César Payán de la Roche. Asociación Colombiana de Terapia Neural (ACOLTEN MNT) en contexto de pandemia. Colombia; 2020 Jun p. 83.Engel R, Barop H, Giebel J, Ludin SM, Fischer L. The Influence of Modern Neurophysiology on the Previous Definitions of “Segment” and “Interference Field” in Neural Therapy. Complement Med Res [Internet]. 2022 [cited 2022 Jun 27];29(3):257–67. Available from: https://www.karger.com/Article/FullText/522391Polymyalgia Rheumatica After ChAdOx1 nCov-19 Vaccine: A Case Report - PMC [Internet]. [cited 2023 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236670/Pinilla L. Validez y fuerza científica de los fundamentos de la Terapia Neural: un estudio de la obra de Speransky. In: Medicina neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá: Universidad Nacional de Colombia; 2013.Toscano de la Torre F, Pinilla Bonilla LB. Los principios de la terapia neural desde los fundamentos del nervismo hasta la neurociencia actual. Rev Univ Ind Santander Salud [Internet]. 2012 [cited 2022 Jan 27];44(2):57–65. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072012000200008Salazar J. La terapia neural: de terapia {ortodoxa" a Medicina Neuralterapéutica. In: Medicina Neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá: Universidad Nacional de Colombia; 2013. p. 51–72.Vinyes D, Muñoz-Sellart M, Caballero TG. Local anesthetics as a therapeutic tool for post COVID-19 patients: A case report. Medicine [Internet]. 2022 Jul 15 [cited 2023 May 26];101(28):e29358. Available from: https://journals.lww.com/md-journal/Fulltext/2022/07150/Local_anesthetics_as_a_therapeutic_tool_for_post.33.aspxAltinbilek T, Terzi R, Kaya E, Murat S. Effects of Local Anesthetics on Viruses from a Neural Therapy Perspective. J Tradit Complem Med. 2021;4(3):394–9.Fu Q, Xie H, Zhou L, Li X, Liu Y, Liu M, et al. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Trials [Internet]. 2021 Feb 25 [cited 2023 Sep 27];22:162. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905419/EstudiantesPúblico generalReceptores de fondos federales y solicitantesLICENSElicense.txtlicense.txttext/plain; charset=utf-85879https://repositorio.unal.edu.co/bitstream/unal/85722/1/license.txteb34b1cf90b7e1103fc9dfd26be24b4aMD51ORIGINAL1125785403.2024.pdf1125785403.2024.pdfTesis de Maestría en Medicina Alternativaapplication/pdf240354https://repositorio.unal.edu.co/bitstream/unal/85722/2/1125785403.2024.pdf2841460412b05ccbc904f7d43dfc00efMD52THUMBNAIL1125785403.2024.pdf.jpg1125785403.2024.pdf.jpgGenerated Thumbnailimage/jpeg4987https://repositorio.unal.edu.co/bitstream/unal/85722/3/1125785403.2024.pdf.jpg676c04148f2ca1a83a467545415ce527MD53unal/85722oai:repositorio.unal.edu.co:unal/857222024-08-23 23:10:16.718Repositorio Institucional Universidad Nacional de Colombiarepositorio_nal@unal.edu.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 |